| Primary |
| Drug Use For Unknown Indication |
75.0% |
| Dementia Alzheimer's Type |
25.0% |
|
|
| Secondary |
| Product Used For Unknown Indication |
45.1% |
| Drug Use For Unknown Indication |
30.4% |
| Ill-defined Disorder |
5.8% |
| Intentional Overdose |
3.2% |
| Mania |
2.6% |
| Hypertension |
2.1% |
| Agitation |
1.9% |
| Aggression |
1.3% |
| Psychotic Disorder |
1.1% |
| Bipolar Disorder |
0.8% |
| Dementia Alzheimer's Type |
0.8% |
| Schizophrenia, Undifferentiated Type |
0.8% |
| Bipolar I Disorder |
0.6% |
| Delirium |
0.6% |
| Dementia |
0.6% |
| Sleep Disorder |
0.6% |
| Personality Disorder |
0.5% |
| Blood Creatinine Increased |
0.3% |
| Epilepsy |
0.3% |
| Hypertensive Crisis |
0.3% |
|
| Suicide Attempt |
16.4% |
| Hypotension |
11.6% |
| Hyponatraemia |
8.9% |
| Pneumonia |
6.8% |
| Tachycardia |
6.2% |
| Lung Infiltration |
5.5% |
| Restlessness |
5.5% |
| Electrocardiogram Qt Prolonged |
4.8% |
| Vomiting |
4.8% |
| Drug Interaction |
4.1% |
| Cardiac Arrest |
3.4% |
| Abasia |
2.7% |
| Diarrhoea |
2.7% |
| Glomerular Filtration Rate Decreased |
2.7% |
| Nausea |
2.7% |
| Sedation |
2.7% |
| Death |
2.1% |
| Drug Ineffective |
2.1% |
| General Physical Health Deterioration |
2.1% |
| Somnolence |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.2% |
| Depression |
12.7% |
| Drug Use For Unknown Indication |
10.0% |
| Insomnia |
4.2% |
| Rheumatoid Arthritis |
3.7% |
| Anxiety |
3.5% |
| Hypertension |
3.3% |
| Schizoaffective Disorder |
3.3% |
| Schizophrenia |
2.7% |
| Dementia Alzheimer's Type |
2.5% |
| Hiv Infection |
2.3% |
| Psychotic Disorder |
2.3% |
| Prophylaxis |
1.7% |
| Schizophrenia, Paranoid Type |
1.7% |
| Prostate Cancer |
1.5% |
| Rhinitis |
1.5% |
| Oesophagitis |
1.3% |
| Blood Testosterone Decreased |
1.2% |
| Folliculitis |
1.2% |
| Muscle Spasms |
1.2% |
|
| Pulmonary Embolism |
8.8% |
| Restlessness |
8.8% |
| Off Label Use |
7.5% |
| Psychotic Disorder |
7.5% |
| Restless Legs Syndrome |
7.5% |
| Ruptured Cerebral Aneurysm |
7.5% |
| Liver Function Test Abnormal |
5.0% |
| Neoplasm Malignant |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Complex Regional Pain Syndrome |
3.8% |
| Loss Of Consciousness |
3.8% |
| Mitral Valve Incompetence |
3.8% |
| Parkinsonism |
3.8% |
| Rhabdomyolysis |
3.8% |
| Sternal Fracture |
3.8% |
| Suicidal Ideation |
3.8% |
| Weight Increased |
3.8% |
| Acute Myocardial Infarction |
2.5% |
| Bronchospasm |
2.5% |
| Drug Level Increased |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
97.5% |
| Depression |
1.7% |
| Musculoskeletal Pain |
0.8% |
|
| Hypotension |
62.5% |
| Syncope |
16.7% |
| Gamma-glutamyltransferase Increased |
8.3% |
| Drug Interaction |
4.2% |
| Polydipsia |
4.2% |
| Sedation |
4.2% |
|
